|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 February 2002, Vol. 99, No. 4, pp. 1449-1457
TRANSPLANTATION
Unique patterns of surface receptors, cytokine secretion, and
immune functions distinguish T cells in the bone marrow from those in
the periphery: impact on allogeneic bone marrow transplantation
Defu Zeng,
Petra Hoffmann,
Fengshuo Lan,
Philip Huie,
John Higgins, and
Samuel Strober
From the Department of Medicine, Division of Immunology
and Rheumatology, and the Department of Pathology, Stanford University
School of Medicine, CA.
The "conventional" NK1.1 T cells from mouse blood
and marrow were compared with regard to surface receptors, cytokine
secretion, and function. Most blood NK1.1
CD4+ and CD8+ T cells expressed the naive
CD44int/loCD62LhiCD45RBhi
T-cell phenotype typical of those in the peripheral
lymphoid tissues. In contrast, most marrow NK1.1
CD4+ and CD8+ T cells expressed an
unusual CD44hiCD62LhiCD45RBhi
phenotype. The blood NK1.1 CD4+ T cells had a
naive T-helper cytokine profile and a potent capacity to induce lethal
graft versus host (GVH) disease in a C57BL/6 donor to a BALB/c host
bone marrow transplantation model. In contrast, the marrow
NK1.1 CD4+ T cells had a Th0 cytokine profile
and failed to induce lethal GVH disease, even at 20-fold higher numbers
than those from the blood. NK1.1 CD8+ T cells
from the blood but not the marrow induced lethal GVH disease.
Nevertheless, the marrow NK1.1 CD8+ T cells
induced potent antitumor activity that was augmented by marrow
NK1.1 CD4+ T cells and facilitated
hematopoietic progenitor engraftment. The inability of marrow
CD4+ and CD8+ T cells to induce GVH disease was
associated with their inability to expand in the blood and gut of
allogeneic recipients. Because neither the purified marrow
CD4+ or CD8+ T cells induced GVH disease, their
unique features are desirable for inclusion in allogeneic bone marrow
or hematopoietic progenitor transplants.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Li, Y. Chen, W. He, T. Yi, D. Zhao, C. Zhang, C.-L. Lin, I. Todorov, F. Kandeel, S. Forman, et al.
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI
Blood,
January 22, 2009;
113(4):
953 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paiardini, B. Cervasi, J. C. Engram, S. N. Gordon, N. R. Klatt, A. Muthukumar, J. Else, R. S. Mittler, S. I. Staprans, D. L. Sodora, et al.
Bone marrow-based homeostatic proliferation of mature T cells in nonhuman primates: implications for AIDS pathogenesis
Blood,
January 15, 2009;
113(3):
612 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chakraverty, B. Flutter, F. Fallah-Arani, H.-S. Eom, T. Means, G. Andreola, S. Schwarte, J. Buchli, P. Cotter, G. Zhao, et al.
The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells
J. Immunol.,
November 15, 2008;
181(10):
6820 - 6828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Palendira, R. Chinn, W. Raza, K. Piper, G. Pratt, L. Machado, A. Bell, N. Khan, A. D. Hislop, R. Steyn, et al.
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow
Blood,
October 15, 2008;
112(8):
3293 - 3302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Li, N. Perez, S. Karumuthil-Melethil, and C. Vasu
Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes
Diabetes,
September 1, 2007;
56(9):
2251 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Chen, D. Deoliveira, X. Cui, N. T. Le, J. Son, J. F. Whitesides, and N. J. Chao
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Blood,
April 1, 2007;
109(7):
3115 - 3123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang, J. Lou, N. Li, I. Todorov, C.-L. Lin, Y.-A. Cao, C. H. Contag, F. Kandeel, S. Forman, and D. Zeng
Donor CD8+ T Cells Mediate Graft-versus-Leukemia Activity without Clinical Signs of Graft-versus-Host Disease in Recipients Conditioned with Anti-CD3 Monoclonal Antibody
J. Immunol.,
January 15, 2007;
178(2):
838 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Z. Yu, Y. Liang, R. I. Nurieva, F. Guo, C. Anasetti, and C. Dong
Opposing Effects of ICOS on Graft-versus-Host Disease Mediated by CD4 and CD8 T Cells.
J. Immunol.,
June 15, 2006;
176(12):
7394 - 7401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rieger, C. Loddenkemper, J. Maul, T. Fietz, D. Wolff, H. Terpe, B. Steiner, E. Berg, S. Miehlke, M. Bornhauser, et al.
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
Blood,
February 15, 2006;
107(4):
1717 - 1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Garcia-Ojeda, S. Dejbakhsh-Jones, D. Chatterjea-Matthes, A. Mukhopadhyay, A. BitMansour, I. L. Weissman, J. M. Y. Brown, and S. Strober
Stepwise Development of Committed Progenitors in the Bone Marrow That Generate Functional T Cells in the Absence of the Thymus
J. Immunol.,
October 1, 2005;
175(7):
4363 - 4373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liang, T. Huang, C. Zhang, I. Todorov, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb
Blood,
March 1, 2005;
105(5):
2180 - 2188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Monteiro, A. Benjamin, E. S. Costa, M. A. Barcinski, and A. Bonomo
Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells
Blood,
February 15, 2005;
105(4):
1484 - 1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Chen, X. Cui, G. D. Sempowski, C. Liu, and N. J. Chao
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease
Blood,
February 15, 2004;
103(4):
1534 - 1541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hoffmann, J. Ermann, M. Edinger, C. G. Fathman, and S. Strober
Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
J. Exp. Med.,
August 5, 2002;
196(3):
389 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Walters, A. W. Nienhuis, and E. Vichinsky
Novel Therapeutic Approaches in Sickle Cell Disease
Hematology,
January 1, 2002;
2002(1):
10 - 34.
[Abstract]
[Full Text]
|
 |
|
|
|